NCT06296875

The Krill Ageing Muscle Mechanisms (KAMM) Study

Name: Clinical Trial NCT06296875
Creator: University of Glasgow
Keywords: Sarcopenia, Vegetable oil, dietary supplement, clinical trial, United Kingdom

Uncovering the Mechanisms Through Which Krill Oil Increases Muscle Function in Older Adults.

University of Glasgow·ClinicalTrials.gov·dietary supplementNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Sarcopenia
Drug/Device/Intervention: Vegetable oil
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: University of Glasgow
Location: Glasgow, United Kingdom

Timeline & enrollment

Phase: N/A
Start date: Mar 01, 2024
End date: Mar 01, 2026
Enrollment: 80 participants

Primary outcome

Grip strength,Neuromuscular junction transmission instability,Gait speed

Summary

This study aims to determine the mechanisms via which krill oil supplementation increases muscle strength and whether this translates to improvements in gait and functional characteristics in older adults. The studies we will carry out will establish, in healthy older adults, the effects of 6 months of supplementation with krill oil  Objective 1) Muscle structure and function Hypothesis: Krill oil supplementation will increase muscle size and strength alongside positive changes in muscle architecture (pennation angle and fascicle length).  Objective 2) Neuromuscular control and central nervous system (CNS) function Hypothesis: Krill oil supplementation will improve Neuromuscular Junction (NMJ) transmission stability and increase central drive and intramuscular coherence, as a measure of muscle synergy.  Objective 3) Gait and functional characteristics Hypothesis: Krill oil supplementation will improve gait and functional characteristics.

ICD-10 classifications

Kaposi sarcomaHerniaTaeniasisTaenia saginata taeniasisDiaphragmatic hernia

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06296875
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06296875 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Glasgow and is currently Not yet recruiting. The study focuses on Sarcopenia. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.